Blood Res.  2020 Sep;55(3):180-181. 10.5045/br.2020.2020093.

Nuances in the management of acquired hemophilia A in an elderly patient with large granular lymphocytic leukemia

• Tiwari NR
• Chaudhari KS
• Rao V
• Sharma VR

• KMID: 2507060
• DOI: http://doi.org/10.5045/br.2020.2020093

Abstract

No abstract available.

Reference

1. Franchini M, Lippi G. 2008; Acquired factor VIII inhibitors. Blood. 112:250–5. DOI: 10.1182/blood-2008-03-143586. PMID: 17124095.

2. Murphy PW, Brett LK, Verla-Tebit E, Macik BG, Loughran TP Jr. 2015; Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia: a case report and review of the literature. Blood Coagul Fibrinolysis. 26:211–3. DOI: 10.1097/MBC.0000000000000209. PMID: 25396761.

3. Kruse-Jarres R, Kempton CL, Baudo F, et al. 2017; Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 92:695–705. DOI: 10.1002/ajh.24777. PMID: 28470674.

4. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. 2003; Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 121:21–35. DOI: 10.1046/j.1365-2141.2003.04162.x. PMID: 12670328.

5. Lamy T, Moignet A, Loughran TP Jr. 2017; LGL leukemia: from pathogenesis to treatment. Blood. 129:1082–94. DOI: 10.1182/blood-2016-08-692590. PMID: 28115367.